In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eileen Francis

Reporter – US

Eileen Francis is a reporter for “The Tan Sheet,” where she follows news on OTC drug and nutritional product manufacturing, regulation, legislation, finance and research. She previously served as a reporter and editor of “The Rose Sheet,” IBI’s source for in-depth coverage of the cosmetics industry. Early in her career, Eileen worked in public relations and as a writer for a lobbying firm. Outside of IBI, her freelance work includes articles on business, art and travel.

Latest From Eileen Francis

US Meeting Set For CBDs’ Impact On Pregnancies, Gender-Specific Biological, Psychosocial Effects

FDA schedules public meeting for 19 November to discuss sex and gender differences in the use and response to cannabidiols. The meeting will address the issue of CBD use in pregnancy, for which no human data currently is available.

Cannabidiol CBD FDA

Head & Shoulders' ‘100%’ Ad Campaign Continues Competition Between Mahomes, Polamalu

Head & Shoulders airing a 30-second TV spot featuring Kansas City Chiefs quarterback Patrick Mahomes and former Pittsburgh Steelers safety Troy Polamalu competing over who gives “100%” effort in everything they do.

OTC Drugs Ad Campaigns

Without US CBD Guidance, Low-Quality Supplements, State Rules Hurt Industry

Responsible CBD supplement marketers are disadvantaged against bad actors with products taking up shelf space in “disloyal” retailers as federal regulatory limbo drags on, says nutritional science expert Duffy McKay. Patchwork of state regulations on CBD also create challenges.

Regulation Cannabidiol CBD

Vitamin D And COVID-19 Studies: Prevention Benefits Suggested By Chicago Research

A study with nearly 500 patients with vitamin D levels tested within a year before receiving COVID-19 tests found subjects deficient in the nutrient had 1.77 greater chance of testing positive. Researchers say RCTs are needed to determine if broad population interventions are necessary.

Research & Development Dietary Supplements

On Appeal To Advertising Experts, P&G Gets Nod For ‘#1’ Claim With Brand Qualifier On Oral-B Picks

National Advertising Review Board says P&G’s #1” claim in a shield-shaped logo on Oral-B Precision Clean Interdental Picks package fronts “is adequately connected to the explanatory information," which states “from the makers of the #1 dentist recommended floss brand.”

Commercial OTC Devices

VGH Solutions Feels Pain In US Review For Basing OTC Device Ad Claims On Canada’s Approval

NAD advises VGH Solutions to pull pain relief claims and statements that am OTC device with FDA 510(k) clearance treats conditions including neuropathy. The firm offered studies and a Health Canada statement listing indications for the device to support claims not part of the US approved indication.

OTC Devices Enforcement
See All
UsernamePublicRestriction

Register